Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
FRIGE's Institute of Human Genetics | RCV000202369 | SCV000257367 | pathogenic | Tay-Sachs disease | 2011-10-01 | criteria provided, single submitter | clinical testing | The mutation p.E462V was found in ten unrelated families from India indicating a founder effect. |
Center for Genomics, |
RCV000202369 | SCV000898736 | pathogenic | Tay-Sachs disease | 2022-03-21 | criteria provided, single submitter | clinical testing | This variant has been reported in the literature in a homozygous or compound heterozygous state with another pathogenic variant, in at least 8 individuals of Indian (Gujarat) ancestry with infantile Tay-Sachs Disease (TSD), suggesting a founder effect (Mistri 2012 PMID:22723944, Sheth 2014 PMID:27896118, Sheth 2018 PMID:29973161). This variant is present in 0.003% (1/30762) of South Asian alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/15-72638612-T-A) with no homozygotes identified. Please note, disease-causing variants may be present in control databases at low frequencies, reflective of the general population, carrier status and/or variable expressivity. This variant is present in ClinVar (Variation ID:218134). Evolutionary conservation and computational predictive tools support that this variant may impact the protein. Computational structural analyses revealed that this residue is located within the active site of the alpha subunit of hexosamindase A and support that this variant may impact the protein (Mistri 2012 PMID:22723944). In summary, this variant is classified as pathogenic. |